Abiopharma

Clinical trial NCT06576050 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2024-11-01 → 2025-08-02

Clinical trial NCT06092970 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-06-30 → 2026-02-06 3. primary completion date: 2026-06-30 → 2026-02-06 4. enrollment: 379 → 353 participants

Clinical trial NCT05450744 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-01 → 2027-06-01 3. primary completion date: 2026-06-01 → 2027-06-01

Clinical trial NCT06384352: intervention model: SINGLE_GROUP → PARALLEL.

MHS Serves Announces Recipients of over $2 Million Investment in Hoosier Employment

XCharge North America Powers the Worlds First All-Electric Aircraft Rescue and Firefighting Vehicle at Dallas Love Field Airport

NeuroSense Issues CEO Letter to Shareholders

Werner® Earns Double Industry Honors for Outstanding Support of Military Veterans and Families

NeuroSense Issues CEO Letter to Shareholders

Clinical trial NCT07157423 updates: 1. completion date: 2027-03-26 → 2027-08-26 2. primary completion date: 2027-03-26 → 2027-08-26